Atlas Trials

Duration of Ameluz Application in Acral Actinic Keratoses Response

Clinical trial NCT03963102 · TERMINATED

Trial details

NCT number
NCT03963102
Sponsor
Royal Cornwall Hospitals Trust
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Actinic KeratosesPhotodamaged Skin
Start date
2019-10-30
Primary completion
2024-03-31
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.